April 9, 2015
Adverse pulmonary reactions to pharmacotherapy can occur if the lung serves as a route for the entry of inhaled therapeutics into the body to treat diseases — or as a consequence of pulmonary toxicity associated with systemic drug exposure. Assessing pulmonary adverse effects of therapeutics has many challenges, and thorough monitoring throughout clinical trials is pivotal to identify any of these detrimental effects in patients. This webinar reviews the clinical manifestations of pulmonary drug reactions and how these can be monitored by current pulmonary function tests.
Event Details Available Here.